Octimet Oncology

Developer of MET kinase inhibitors for the treatment of cancer

placeBeerse, Flanders, Belgium calendar_todayFounded 2016 groups1 employees language octimet.com

Registered entities

Investor mix

7 investors on record; lead investors include V-Bio Ventures, VIB.

Investor typeCountShare
Venture capital343%
Private equity114%
Accelerator & incubator114%
Other / undisclosed229%
Coming soon